is retatrutide a glp-3 Triple Agonist Peptides Explained: Retatrutide, GLP-3, and the Future of Metabolic Research NEW GPL 3 | WE

Researchers at UTHealth Houston described orforglipron's potential to become "the Metformin of obesity", a widely accessible, affordable, and scalable first-line treatment

Differential Risk of Cancer Associated with Glucagon-like Peptide-1 Receptor Agonists: Analysis of Real-world Databases

Appetite Suppression: It signals the brain that you are full

1 / 2 2 / 2 Dr Kavita Sharma (GMC 7039911), a Specialist Registered Consultant Plastic Surgeon with expertise in body contouring, microsurgical and oncoplastic breast reconstruction, has trained extensively across leading centres throughout the UK

Symptomatic magnesium deficiency remains relatively uncommon, but awareness of potential risk factors allows for appropriate clinical vigilance, particularly in patients with persistent gastrointestinal symptoms or those on multiple medications affecting mineral balance